Prestizia's Acquisition

Prestizia was acquired by Theradiag on June 28, 2012.

Prestizia, a biotechnology company that is developing a microRNA technology. Prestizia is a subsidiary of the Holding Incubatrice Biotechnology and Pharmacy. In June 2012, Prestizia was acquired by T…

Articles about Prestizia's Acquisition: